
BASINGSTOKE, England, May 11 (UPI) -- Shire said Friday a British court set June 25 as the start date of a challenge to the government's decision not to support Alzheimer's drugs.
The Judicial Review in the High Court involves the National Institute for Health and Clinical Excellence's guidance to refuse National Health Service support of drugs for new patients with mild Alzheimer's disease. The outcome of the case could affect the support of Shire's drugs Reminyl and Reminyl XL.
"Shire is pleased that, by arranging the hearing for the first possible date, James Goudie QC has acknowledged the importance and urgency of this matter to the general public and to the many thousands who will be diagnosed with Alzheimer's disease of mild severity this year," said John Freeman, managing director of Shire's UK commercial operation
"Shire agrees completely with the grounds for the Judicial Review and will be supporting all stakeholders by participating in the High Court action as an interested party," Freeman added.
|
|
|
|
|
|
| Additional Health News Stories | |
MIAMI, May 27 (UPI) --
Tropical Storm Beryl neared hurricane strength ahead of its expected landfall Sunday night on the Southeast Coast of the United States, U.S. forecasters said.
|
'Men in Black' leads U.S. box office ... Michelle Obama, daughters see Beyonce ... Lady Gaga cancels Jakarta gig for security ... Madonna asks for pool at Israel venue ... News from United Press International.
|
ANCHORAGE, Alaska, May 27 (UPI) --
A black bear didn't go over a river but went to the woods after scampering through residential and industrial areas of Anchorage, Alaska, police said.
|
To avoid a meltdown in 2006, Ford Motor Co. mortgaged the farm putting up its assets – including its Blue Oval logo, and F-150 pickup and iconic Mustang trademarks – to secure $23.5 billion in credit.
|
| Stories | Photos | People | Comments |
View Caption